Model applicable for patients with early-stage cervical cancer (T1a–T2b) after primary surgical treatment.
Model is developed on data from 4,343 patients treated in 20 tertiary centres on 4 continents.
It has been evaluated by 10-fold cross-validation within the imputed data set.
The resulting median
C index equals 0.732*
DFS represents a % probability of survival without disease recurrence at the respective time point.
| Years since surgery | DFS (95% confidence interval) |
|---|---|
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5 |
| Type of recurrence |
|
| Recurrence localisation |
|